The Department of Health and Human Services is offering an SBIR grant to support the research and development of new technologies and bioengineering solutions for advancing cell replacement therapies for Type 1 Diabetes. This grant aims to fund innovative approaches, biomaterials, and devices that enhance interventions for T1D treatment. Closing date for applications is November 3, 2020, 12:00 AM EST.
Opportunity ID: 322967
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DK-19-028 |
Funding Opportunity Title: | Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Food and Nutrition Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 10, 2019 |
Last Updated Date: | Dec 10, 2019 |
Original Closing Date for Applications: | Nov 03, 2020 |
Current Closing Date for Applications: | Nov 03, 2020 |
Archive Date: | Dec 09, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for the eligibility details |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-028.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257081 | Mar 09, 2020 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260300 | Mar 09, 2020 | Nov 03, 2020 | View |
Package 1
Mandatory forms
322967 RR_SF424_2_0-2.0.pdf
322967 PHS398_CoverPageSupplement_4_0-4.0.pdf
322967 RR_OtherProjectInfo_1_4-1.4.pdf
322967 PerformanceSite_2_0-2.0.pdf
322967 RR_KeyPersonExpanded_2_0-2.0.pdf
322967 RR_Budget_1_4-1.4.pdf
322967 PHS398_ResearchPlan_4_0-4.0.pdf
322967 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
322967 RR_SubawardBudget30_1_4-1.4.pdf
322967 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
322967 RR_SF424_2_0-2.0.pdf
322967 PHS398_CoverPageSupplement_5_0-5.0.pdf
322967 RR_OtherProjectInfo_1_4-1.4.pdf
322967 PerformanceSite_2_0-2.0.pdf
322967 RR_KeyPersonExpanded_2_0-2.0.pdf
322967 RR_Budget_1_4-1.4.pdf
322967 PHS398_ResearchPlan_4_0-4.0.pdf
322967 SBIR_STTR_Information_1_3-1.3.pdf
322967 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
322967 RR_SubawardBudget30_1_4-1.4.pdf
322967 PHS_AssignmentRequestForm_3_0-3.0.pdf